🔎 Trials Near Me

Beranda › Limfoma › Illinois › Chicago

Uji klinis Limfoma di Chicago, IL

20 studi untuk Limfoma mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Menerima pesertaFase 2
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07015242

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Menerima pesertaFase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Menerima pesertaFase 3
  • Research Site, Chicago
Usia 18 hingga 18 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Menerima pesertaFase 1
  • University of Illinois Cancer Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06624085

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

Menerima pesertaFase 1/2
  • University of Chicago, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Menerima pesertaFase 1/2
  • University of Chicago Medical Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Menerima pesertaFase 1
  • The David and Etta Jonas Center for Cellular Therapy, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Menerima pesertaFase 3
  • Northwestern, Chicago
  • University of Chicago, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

Menerima peserta
  • Northwestern University Feinberg School of Medicine, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06960993

DALY II USA/ MB-CART2019.1 for DLBCL

Menerima pesertaFase 2
  • Robert H Lurie Cancer Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Menerima pesertaFase 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT02332668

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Menerima pesertaFase 1
  • Northwestern University, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05131022

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Menerima pesertaStudi observasional
  • Lurie Children's Hospital-Chicago, Chicago
Semua usia · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Menerima pesertaFase 1/2
  • Northwestern Memorial Hospital, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Menerima pesertaFase 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Usia 12 hingga 95 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Menerima pesertaFase 1
  • The University of Chicago Medical Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT04830137

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

Menerima pesertaFase 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT07294677

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Menerima peserta
  • University of Chicago Comprehensive Cancer Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT05745285

Avo In R/R And Previously Untreated MCL

Menerima pesertaFase 1/2
  • University of Chicago Medical Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT04855695

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Menerima pesertaFase 1
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2025 · NCT04234048

Uji klinis Limfoma di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.